Amphadase

Amphadase is a brand name of hyaluronidase, approved by the FDA in the following formulation(s):

AMPHADASE (hyaluronidase - injectable; injection)

• 
  Manufacturer: AMPHASTAR PHARM
  
  Approval date: October 26, 2004
  
  Strength(s): 150 UNITS/ML ^[RLD]

Has a generic version of Amphadase been approved?

No. There is currently no therapeutically equivalent version of Amphadase available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Amphadase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Amphadase.

See also...

• Amphadase Consumer Information (Drugs.com)
• Amphadase Consumer Information (Wolters Kluwer)
• Amphadase injectable Consumer Information (Cerner Multum)
• Amphadase Advanced Consumer Information (Micromedex)
• Hyaluronidase Consumer Information (Wolters Kluwer)
• Hyaluronidase injectable Consumer Information (Cerner Multum)
• Hyaluronidase Subcutaneous, Injection Advanced Consumer Information (Micromedex)